Israeli Humanitarian Aid Delegation Departs for Türkiye
‘We’ll do our best to save lives’: IDF rescue delegation arrives in southern Turkey
Prof. Polina Stepensky Explains The CAR (Chimeric Antigen Receptor) T-Cell Therapy.
Hadasit, the Innovation Engine of Hadassah Medical Organization and BIRAD, the Commercialization arm of Bar-Ilan University announced today that they have entered into the research and license agreement with Immix BioPharma, for the development and commercialization of novel tissue specific therapeutics based on anti-BCMA CAR-T cells targeting plasma cell. This technology has been developed as the result of a collaboration between Prof. Polina Stepensky, of Hadassah Medical Center, Jerusalem and Prof. Cyrille J. Cohen, of Bar-Ilan University, Ramat Gan. Dr. Shlomit Kfir-Erenfeld and Dr. Nathalie Asherie, of Hadassah Medical Center, and Ortal Harush, of Bar-Ilan University, also participated in the research.
For more information visit Yahoo! Finance
Long COVID: Hyperbaric Oxygen Therapy Offers Hope for Understanding and Treating Symptoms
Hyperbaric oxygen therapy in a randomized placebo-controlled trial resulted in improved global cognitive function, energy, sleep, and pain interference in long COVID patients.
COVID-19 vaccine provides effective protection against Omicron pregnancy risks
Vials representing the mRNA coronavirus disease (COVID-19) vaccine candidate developed by Sinopharm’s China National Biotec Group (CNBG) are seen displayed at its booth at the 2021 China International Fair for Trade in Services (CIFTIS) in Beijing, China September 3, 2021.
(photo credit: REUTERS/FLORENCE LO)
Hadassah Hospital’s First Babies Of 2023
The celebration of new life is a momentous moment at the dawn of a new year. Hadassah Hospital is delighted to welcome its firstborn of 2023. At the stroke of midnight at Hadassah Mount Scopus, a sweet baby girl was born to Reut and Harel, adding to their ever-growing family of three children – all […]
Technology helping Israel cure cancer in children
“Other than genomics, the other reason why the survival rate is high is due to better diagnostic tools that allow doctors to get a better view into how patients are responding to treatments and improve their ability to provide personalized care,” said Dr. Goldstein.
Hadassah Medical Center makes Newsweek’s list of top cardiology centers
Newsweek magazine has selected the Cardiology and Oncology (Sherett Institute) Divisions of Hadassah Medical Center for their list of the best hospitals in the world. Newsweek magazine has selected the Cardiology and Oncology (Sherett Institute) Divisions of Hadassah Medical Center for their list of the best hospitals in the world specializing in various medical fields […]
Just get vaccinated
Prof. Itai Shavit: Just get vaccinated My recommendation every year – but this year in particular – is to vaccinate the whole family with the flu vaccine. This is my advice to all parents and children who wish for themselves an easier year in terms of winter illnesses, and dealing with these illnesses in […]
New Study Reveals Effective Treatment for Children Suffering From Persistent Post-Concussion Syndrome
Study shows that hyperbaric oxygen therapy significantly improves symptoms, including memory, emotional and behavioral, and heals brain structure in cortical regions Today, Aviv Clinics highlights a new study published in Scientific Reports showing an effective treatment to heal damaged brain tissue and relieve symptoms in children experiencing persistent post-concussion syndrome (PPCS). The study, conducted by the Sagol Center for […]
Merck, Hadassah launch collaboration to use RNA-based therapeutics to fight cancer
Pharmaceutical company Merck and Hadassah University Hospital in Jerusalem launched CanceRNA, which aims to use messenger-RNA technology to treat cancer. Regine Shevach, the head of Merck’s Innovative Technologies Enablement Center in Israel, has always believed in collaborations. “In the past, projects usually happened within the same industry,” she said. “Today, however, things have changed, and […]
